Bladder-Preserving Gemcitabine plus Docetaxel Shows Durable Results After Failed BCG Therapy
An updated systematic review of 12 studies in 1,248 patients finds sequential intravesical gemcitabine plus docetaxel offers durable disease control ...
An updated systematic review of 12 studies in 1,248 patients finds sequential intravesical gemcitabine plus docetaxel offers durable disease control ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.